Drug Type Proteolysis-targeting chimeras (PROTAC) |
Synonyms HD-TAC5 |
Target |
Action degraders, inhibitors |
Mechanism HDAC2 degraders(Histone deacetylase 2 degraders), HDAC2 inhibitors(Histone deacetylase 2 inhibitors), Epigenetic drug |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC34H35N7O7 |
InChIKeyCRAUZVPYAMLRRZ-UHFFFAOYSA-N |
CAS Registry2978763-94-7 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Inflammation | Preclinical | Netherlands | 01 Dec 2020 |